![Peter Ratcliffe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Ratcliffe
Direktor/Vorstandsmitglied bei
IMMUNOCORE HOLDINGS PLC
Vermögen: 9 620 $ am 31.05.2026
Profil
Mr. Peter J.
Ratcliffe is an Independent Non-Executive Director at Immunocore Holdings Plc, a Director-Clinical Research at The Francis Crick Institute Ltd., a Director-Target Discovery Institute at University of Oxford, a Member at American Academy of Arts & Sciences and a Member at European Molecular Biology Organization.
He is on the Board of Directors at Immunocore Holdings Plc, ReOx Ltd., Target Discovery Institute and Immunocore Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 333 ( 0% ) | 9 620 $ | 31.05.2026 |
Aktive Positionen von Peter Ratcliffe
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Direktor/Vorstandsmitglied | 01.11.2020 |
ReOx Ltd.
 ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Gründer | 01.06.2003 |
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Corporate Officer/Principal | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Direktor/Vorstandsmitglied | - |
Target Discovery Institute | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
93
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReOx Ltd.
ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
European Molecular Biology Organization | |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Miscellaneous |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Target Discovery Institute | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
